Anti-EBV/HHV4 BLLF1/MA/GP350 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22270; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing our Anti-EBV/HHV4 BLLF1/MA/GP350 Polyclonal Antibody – the perfect solution for your biotech research needs.
This highly specific antibody is designed to target the Epstein-Barr virus (EBV) and human herpesvirus 4 (HHV4), specifically the BLLF1/MA/GP350 protein. It is derived from rabbit serum and has been validated for use in various applications, making it a valuable tool for any biotech laboratory.
The biological function of this antibody lies in its ability to bind to the BLLF1/MA/GP350 protein, which is a key component of the EBV/HHV4 virus. By binding to this protein, the antibody can effectively neutralize the virus and prevent its replication, making it an essential tool for studying the pathogenesis of EBV/HHV4 and developing potential treatments.
This antibody has a wide range of applications, including immunofluorescence, immunohistochemistry, and Western blotting. It has been extensively tested and has shown high specificity and sensitivity in detecting the BLLF1/MA/GP350 protein in various sample types, including tissue sections and cell lysates.
In addition to its main applications, this antibody has also been used in various experimental studies. It has been shown to effectively inhibit EBV/HHV4 infection in vitro, making it a valuable tool for studying the virus and its potential treatments. Furthermore, it has been used in vaccine development research, as targeting the BLLF1/MA/GP350 protein has been shown to induce a strong immune response against EBV/HHV4.
With its high specificity, sensitivity, and versatility, our Anti-EBV/HHV4 BLLF1/MA/GP350 Polyclonal Antibody is a must-have for any biotech researcher studying EBV/HHV4.
ProteoGenix catalogue number ARO-A22270. For research use only.
Target: Envelope glycoprotein GP350, Membrane antigen, MA; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Envelope glycoprotein GP350, Membrane antigen, MA |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
